Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vestre Viken Hospital Trust
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients who according to the compound's Norwegian prescription guidelines are deemed eligible for the study, i.e. MS patients with impaired walking as determined by an EDSS 4-7. They do not need a past history of optic neuritis, cognitive failure, fatigue or difficulties micturating.
You may not be if
MS patients with contraindications to the compound according to the prescription guidelines.
Patients who have been exposed to Fampyra in the past Patients with an MS attack within last 3 months
